SECTION 6.4
Inhibition
101
HC>
H7C30
OC,H7
.
v z / ~ H - ( p -
. / +H20
Regenerated
enzyme
hao
lN:
3 r
+H,0
O,
Phosphorylated
enzyme
Oxime-phosphonate
x y
--------> Nr H— 0 /
Regenerated
enzyme
FIG U R E 6-10
Reactivation of alkylphosphorylated acetylcholinesterase. Spontaneous reactivation (dashed arrow) by water occurs at
an insignificant rate; however, loss of one isopropoxy group occurs at a much more rapid rate, yielding the “aged”
enzyme, which is resistant to reactivation. The regeneration of the enzyme by pralidoxime is shown at bottom.
normal cells are not affected by HCN because they contain
CN_-inactivating enzyme (rhodanese; see below). No ob-
jective evidence demonstrates any therapeutic value for
these compounds as anticancer agents. Their ingestion has
led to severe toxicity in some reported cases.
Nondietary sources of cyanide include sodium nitro-
prusside (a hypotensive agent), succinonitrile (an antide-
pressant agent), acrylonitrile (used in the plastic industry
and as a fumigant to kill dry-wood termites), and tobacco
smoke. Chronic exposure to cyanogenic compounds leads
to toxic manifestations such as demyelination, lesions of
the optic nerves, ataxia (failure of muscle coordination),
and depressed thyroid functions. This last effect arises
from accumulation of thiocyanate, the detoxified prod-
uct of cyanide in the body (see below). Thiocyanate in-
hibits the active uptake of iodide by the thyroid gland and,
therefore, the formation of thyroid hormones (Chapter 33).
Acute cyanide poisoning requires prompt and rapid
treatment. The biochemical basis for an effective mode
of treatment consists of creating a relatively nontoxic
porphyrin-ferric complex that can compete effectively
with cytochrome oxidase for binding the cyanide ion. This
is accomplished by the administration of nitrites (NaNC
>2
solution intravenously, and amylnitrite by inhalation),
which convert a portion of the normal oxygen-carrying
hemoglobin with divalent iron to oxidized hemoglobin
(i.e., methemoglobin with trivalent iron, which does
not transport oxygen). Methemoglobin binds cyanide
to form cyanomethemoglobin, whose formation is fa-
vored because of an excess of methemoglobin rela-
tive to cytochrome oxidase. This process may lead to
the restoration of normal cytochrome oxidase activity
(Figure 6-12). Cyanomethemoglobin is no more toxic than
methemoglobin and can be removed by normal processes
that degrade erythrocytes and by the reaction catalyzed
by rhodanese. Rhodanese (thiosulfatecyanide sulfurtrans-
ferase) catalyzes the reaction involving cyanide and thio-
sulfate to form thiocyanate:
SSO j' + enzyme = SOj- +
enzyme-S
Thiosulfate
Sulfite
Sulfur-substituted enzyme
Enzyme-S + CN_
—>
SCN-
+ enzyme
(Cyanide)
Thiocyanate
previous page 131 Bhagavan Medical Biochemistry 2001 read online next page 133 Bhagavan Medical Biochemistry 2001 read online Home Toggle text on/off